ArticleNanomaterials (Basel, Switzerland)2022
Thermo-Optical Characterization of Therminol55 Based MXene-Al
Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Characterization and machine learning analysis of hybrid alumina-copper oxide nanoparticles in therminol 55 for medium temperature heat transfer fluid.Scientific reports · 2025Article
- Synthesis, thermophysical characterization and thermal performance analysis of novel Cu-MXene hybrid nanofluids for efficient coolant applications.RSC advances · 2023Article
- Nanomaterials Based on Collaboration with Multiple Partners: ZnInternational journal of molecular sciences · 2023Article
- Thermodynamic Analysis of a Flat Plate Solar Collector with Different Hybrid Nanofluids as Working Medium-A Thermal Modelling Approach.Nanomaterials (Basel, Switzerland) · 2023Article
- Thermohydraulic performance investigation of a heat exchanger with combined effect of ribbed insert and Therminol55/MXene+ AlHeliyon · 2023Article
- Insight into the Investigation of Diamond Nanoparticles Suspended TherminolNanomaterials (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The current research focuses on formulating a new class of Therminol55-based nanofluids that incorporates an MXene/Al
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.